Health Condition 1: null- Paediatric Cancers
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either gender and age between 3months -15 years(19) diagnosed with cancer and has received treatment for atleast 6 weeks duration. 2. Legally Acceptable Representative(LAR)of the patient willing to give voluntary informed consent. 3. Patient between the age 7-12 years willing to give voluntary verbal assent. 4.Patient above the age of 12 years willing to give voluntary informed assent.
Exclusion criteria
Exclusion criteria: Any other medical condition, which in the opinion of the investigator precludes the inclusion of the participant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the prescription pattern of drugs used in treatment of paediatric cancer patientsTimepoint: February 2018 - December 2019 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the off-label use of anti-cancer drugs used in paediatric oncology.Off label use will be analyzed using the following information about the anti-cancer drugs prescribed â?? 1.Dose 2.Dosage form 3.Frequency of administration 4.Indication of the drug 5.Route of administration Timepoint: February 2018 - December 2019 | — |
Countries
India
Contacts
Seth G S Medical College and KEM Hospital